Viewing StudyNCT02283190



Ignite Creation Date: 2024-05-06 @ 3:23 AM
Last Modification Date: 2024-10-26 @ 11:33 AM
Study NCT ID: NCT02283190
Status: COMPLETED
Last Update Posted: 2018-03-12
First Post: 2014-10-17

Brief Title: 1336GCC Study of Erwinaze for Treatment of Acute Myeloid Leukemia AML
Sponsor: Ashkan Emadi
Organization: University of Maryland Baltimore

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-04
Start Date Type: None
Primary Completion Date: 2015-12
Primary Completion Date Type: ACTUAL
Completion Date: 2017-09
Completion Date Type: ACTUAL
First Submit Date: 2014-10-17
First Submit QC Date: October 31 2014
Study First Post Date: 2014-11-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-03-08
Last Update Post Date: 2018-03-12
Last Update Post Date Type: ACTUAL